The Mundipharma network of independent associated companies has a presence in more than 120 countries worldwide including over 30 in Europe.
The network’s autonomous structure allows each independent associated company to concentrate and tailor activities to its own market, in particular the specific needs of the patients and physicians it serves. It can also more easily keep pace with local regulatory and healthcare sector developments. At the same time, having ready access to the combined scale, development and commercial expertise of the wider network is enormously beneficial.
Press return to search